<div id="readability-page-1"><p>Armstrong Advisory Group Inc. increased its holdings in  Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 1,631.7% during the 2nd quarter, according to its most recent 13F filing with the Securities &amp; Exchange Commission. The institutional investor  owned 710 shares of the biotechnology company's stock after buying an additional 669 shares during the period. Armstrong Advisory Group Inc.'s holdings in Axon Enterprise were worth $588,000 as of its most recent SEC filing.</p><div><p><span></span><span>Get <strong>Axon Enterprise</strong> alerts:</span></p></div><ul><li>Why Axon's 16% Surge Signals a New Era in Public Safety Tech</li></ul><p>Other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in shares of  Axon Enterprise by 2.2% during the 1st quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company's stock worth $4,540,005,000 after purchasing an additional 185,571 shares in the last quarter.  Alliancebernstein L.P. grew its holdings in  Axon Enterprise by 15.9% during the 1st quarter. Alliancebernstein L.P. now owns 1,284,935 shares of the biotechnology company's stock valued at $675,812,000 after buying an additional 175,890 shares during the last quarter.  Westfield Capital Management Co. LP increased its position in  Axon Enterprise by 29.8% during the 1st quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company's stock worth $487,977,000 after purchasing an additional 212,931 shares in the last quarter.  GAMMA Investing LLC lifted its holdings in  Axon Enterprise by 58,725.5% in the 1st quarter. GAMMA Investing LLC now owns 764,731 shares of the biotechnology company's stock valued at $402,210,000 after purchasing an additional 763,431 shares in the last quarter.  Finally, Northern Trust Corp boosted its stake in shares of  Axon Enterprise by 1.2% during the 1st quarter. Northern Trust Corp now owns 725,720 shares of the biotechnology company's stock worth $381,692,000 after purchasing an additional 8,794 shares during the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors. </p><h2>Insider Buying and Selling at Axon Enterprise</h2><p>In related news, CAO Jennifer H. Mak sold 77 shares of the business's stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $760.00, for a total value of $58,520.00. Following the completion of the sale, the chief accounting officer owned 15,003 shares of the company's stock, valued at approximately $11,402,280. The trade was a 0.51% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction on Monday, September 8th. The stock was sold at an average price of $743.64, for a total transaction of $7,436,400.00. Following the transaction, the chief executive officer directly owned 3,043,982 shares in the company, valued at $2,263,626,774.48. The trade was a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 44,932 shares of company stock valued at $34,408,816 in the last quarter. Corporate insiders own  4.40% of the company's stock. </p><h2>Axon Enterprise Stock Up 1.1%</h2><ul><li>MarketBeat Week in Review – 06/02 - 06/06</li></ul><p>AXON stock opened at $774.53 on Monday. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. The firm has a market capitalization of $60.80 billion, a P/E ratio of 191.24, a P/E/G ratio of 28.43 and a beta of 1.40. Axon Enterprise, Inc has a 52-week low of $387.06 and a 52-week high of $885.91. The company's 50 day simple moving average is $759.97 and its 200-day simple moving average is $696.68. </p><p>Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The firm had revenue of $668.54 million for the quarter, compared to analysts' expectations of $641.77 million. The company's quarterly revenue was up 32.6% compared to the same quarter last year. During the same period in the previous year, the company posted $1.20 EPS.  Axon Enterprise has set its FY 2025 guidance at  EPS. As a group, equities research analysts anticipate that  Axon Enterprise, Inc will post 5.8 EPS for the current year. </p><h2>Wall Street Analyst Weigh In</h2><ul><li>AXON: Competition Intensifies as Motorola Makes $4.4B Acquisition</li></ul><p>A number of research firms have recently weighed in on AXON. Raymond James Financial  reissued an &#34;outperform&#34; rating and issued a $855.00 price objective (up previously from $645.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Zacks Research lowered Axon Enterprise from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Tuesday, September 2nd. JPMorgan Chase &amp; Co. lifted their price objective on Axon Enterprise from $730.00 to $850.00 and gave the company an &#34;overweight&#34; rating in a research report on Thursday, July 17th. UBS Group  reiterated a &#34;neutral&#34; rating and issued a $840.00 target price (up from $820.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Finally, Morgan Stanley  set a $885.00 price target on Axon Enterprise and gave the stock an &#34;overweight&#34; rating in a research note on Friday, July 11th. Thirteen research analysts have rated the stock with a Buy rating and three have assigned  a Hold rating to the company. According to data from MarketBeat.com, the company  has an average rating of &#34;Moderate Buy&#34; and an average price target of $837.69.</p><p><b>View Our Latest Analysis on AXON</b></p><h2>Axon Enterprise Company Profile</h2> (Free Report)<p>Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Axon Enterprise</li><li>What Are the U.K. Market Holidays? How to Invest and Trade</li><li>3 Overlooked Value Stocks Set to Surge as Rates Drop</li><li>How to invest in marijuana stocks in 7 steps </li><li>Hims &amp; Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy</li><li>Roth IRA Calculator: Calculate Your Potential Returns</li><li>After the Fed's Rate Cut, PNC Could See a Mortgage Refinance Boom</li></ul><p><strong>Want to see what other hedge funds are holding AXON?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVhPTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVhPTg"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Axon Enterprise Right Now?</h2><p>Before you consider Axon Enterprise, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.</p><p>While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

AXON

<p>Armstrong Advisory Group Inc. increased its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 1,631.7% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission.</p>

Axon Enterprise, Inc $AXON Shares Acquired by Armstrong Advisory Group Inc.